Clinical Trial Update: Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial comparing safety and tolerability of PRO-087 to Xyel Ofteno® and Systane Ultra® on the ocular surface in healthy subjects; completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• PRO-087 (null)
• Systane Ultra
• Xyel Ofteno® (null)

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Dry Eye Syndromes, Lubricant Allergy | Phase 1 | Status: COMPLETED | Results posted: 2019-07-19